Ankara City Hospital
Turkey has started to administer its homegrown COVID-19 vaccine candidate to volunteers at a major hospital in the capital Ankara as part of the jab's Phase 3 clinical trials to compare its efficacy to that of the Chinese-developed CoronaVac shot, the country's top health official announced on July 16.
The first doses of the Pfizer-BioNTech vaccine were administered in Turkey's capital Ankara on April 2.
Turkey has so far received 2.8 million doses of the vaccine, which was developed by second-generation Turkish immigrants in Germany.
The total is set to reach 4.5 million in the coming weeks, Health Minister Fahrettin Koca told reporters in parliament on Tuesday.
Over 650,000 health care workers in Turkey have received a dose of a COVID-19 vaccine in the first three days of the vaccination campaign in the country.
Turkey started administering the CoronaVac vaccine developed by China's Sinovac Biotech company to health care staff on Jan. 14.
The first batch of 3 million doses of the vaccine arrived in Turkey on Dec. 30.
Turkey has brought wounded people in a suicide attack in Mogadishu over the weekend, to the capital Ankara on Jan. 21.
Turkish Health Minister Fahrettin Koca told Anadolu Agency that transport aircraft belongs to the Turkish Armed Forces (TSK) was transformed into an air ambulance to bring 10 injured in the attack on the instructions of President Recep Tayyip Erdoğan.